The Functional Role of CYP2B6 in Human Drug Metabolism: Substrates and Inhibitors In Vitro, In Vivo and In Silico

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|7|7|705-714

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.7, Iss.7, 2006-10, pp. : 705-714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro

By Desta Zeruesenay   Saussele Tanja   Ward Bryan   Blievernicht Julia   Li Lang   Klein Kathrin   Flockhart David A   Zanger Ulrich M  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 547-558

Future Medicine

Access to resources Recommend Favorite

Molecular Characterization of CYP2B6 Substrates

By  

Current Drug Metabolism, Vol. 9, Iss. 5, 2008-06 ,pp. : 363-373

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of In Vivo Drug-Drug Interactions from In Vitro Data: Factors Affecting Prototypic Drug-Drug Interactions Involving CYP2C9, CYP2D6 and CYP3A4

By Brown Hayley S.   Galetin Aleksandra   Hallifax David   Houston J. Brian  

Clinical Pharmacokinetics, Vol. 45, Iss. 10, 2006-01 ,pp. : 1035-1050

Adis International

Access to resources Recommend Favorite

Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m‐hydroxymexiletine

By  

Pharmacology Research & Perspectives, Vol. 3, Iss. 5, 2015-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human Cytochromes P450 Associated with the Phase 1 Metabolism of Drugs and other Xenobiotics: A Compilation of Substrates and Inhibitors of the CYP1, CYP2 and CYP3 Families

By  

Current Medicinal Chemistry, Vol. 10, Iss. 19, 2003-10 ,pp. : 1955-1972

Bentham Science Publishers

Access to resources Recommend Favorite